All supplements

Supplement evidence

007 / 575Mineral

Magnesium

View my plan

The short answer

Correcting deficiency; selected compounds also work as clinically used laxatives.

Evidence and scope
Conditional or population-specific

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Broad claims for sleep, stress, testosterone, or longevity remain inconsistent in people without deficiency.
Before deciding
Supplemental magnesium commonly causes diarrhea; impaired kidneys increase toxicity risk.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Meeting usual needsFood first; U.S. supplemental upper limit is 350 mg/day for self-directed use

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source
Confirmed deficiencyForm and dose should follow cause, kidney function, and tolerance

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFormulation-dependent

Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.

How it is commonly taken

Often better tolerated with food; divide larger doses.

Do not combine casually

Separate from tetracycline/quinolone antibiotics and bisphosphonates; kidney impairment increases toxicity risk.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

5research papers in this ledger
14unique primary studies represented
886unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2025
Mixed or qualifiedPMID 40918053 · DRKS00031494

Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial

Insomnia scores improved slightly more than placebo, but the effect was small (Cohen’s d = 0.2) and other psychological outcomes did not differ.

Study design and methods
Design
Randomized, double-blind, placebo-controlled trial
Population
Adults aged 18–65 reporting poor sleep quality
Intervention
Magnesium bisglycinate providing 250 mg elemental magnesium daily versus placebo
Outcome
Insomnia Severity Index and psychological questionnaires

Funding or conflict note: One author leads a contract research organization funded by nutraceutical companies and has received nutraceutical presentation honoraria.

Open research record
2021
Mixed or qualifiedPMID 33865376

Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis

Sleep onset was 17.36 minutes earlier in the pooled estimate, but total sleep time was not significantly improved. All three trials had moderate-to-high risk of bias and the evidence was low to very low certainty.

Study design and methods
Design
Systematic review and meta-analysis of randomized trials
Population
Older adults with insomnia
Intervention
Oral magnesium versus placebo
Outcome
Sleep onset latency, total sleep time, sleep quality, and adverse events
Open research record
2021
Evidence contextPMID 34111673

Bioavailability of magnesium food supplements: A systematic review

Inorganic formulations appeared less bioavailable than organic formulations and absorption was dose-dependent. The authors cautioned that findings could not be assumed to apply to older, ill, or magnesium-deficient people.

Study design and methods
Design
Systematic review of formulation-comparison studies
Population
Human participants in 14 selected studies
Intervention
Different organic and inorganic magnesium formulations
Outcome
Absorption and bioavailability

Funding or conflict note: The authors reported no known competing financial interests or personal relationships.

Open research record
2020
Does not support the tested claimPMID 32956536 · CD009402

Magnesium for skeletal muscle cramps

Magnesium was unlikely to provide clinically meaningful prevention for idiopathic cramps in older adults. Pregnancy findings conflicted, and no randomized trials addressed exercise-associated cramps.

Study design and methods
Design
Cochrane systematic review of randomized trials
Population
Older adults with idiopathic cramps, pregnant people, and a small cirrhosis group
Intervention
Oral or intravenous magnesium versus placebo or another comparator
Outcome
Cramp frequency, intensity, duration, and adverse events
Open research record
2018
Mixed or qualifiedPMID 29131326

Magnesium in Migraine Prophylaxis—Is There an Evidence-Based Rationale? A Systematic Review

Five eligible trials produced Grade C, “possibly effective” evidence. Results were not consistently positive, and the review highlighted 600 mg magnesium dicitrate as the best-supported studied regimen.

Study design and methods
Design
Systematic review of randomized, double-blind, placebo-controlled trials
Population
Adults aged 18–65 with migraine
Intervention
Preventive magnesium regimens versus placebo
Outcome
Migraine days and attacks
Open research record
Unscreened discovery appendix—not evidence436 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis.Mohammadi S, Palermo A, Ojani P et al. · 2026 · Nutrients · PMID 42588058Open on PubMed
  2. The effect of oral magnesium supplementation on glycemic control and metabolic parameters in type 2 diabetes mellitus: a double-blind randomized controlled trial.Al-Maqbali JS, Al Alawi AM, Osman A et al. · 2026 · Frontiers in endocrinology · PMID 42534812Open on PubMed
  3. Magnesium Sulfate to Prevent Perioperative Atrial Fibrillation in Cardiac Surgery: A Randomized Clinical Trial.Meerman M, Buijser M, Neto AS et al. · 2026 · Critical care medicine · PMID 42206948Open on PubMed
  4. Effects of magnesium supplementation on serum brain-derived neurotrophic factor levels and cognitive function in patients undergoing fluoxetine therapy for depression.Noor NJ, Syamsuddin S, Liaury K et al. · 2026 · East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan · PMID 42374947Open on PubMed
  5. The Role of Electrolytes in Muscle Pain Syndromes: A Systematic Review and Meta-Analysis With Implications for Temporomandibular Disorder.Patil S, Falkowski A, Venkataiah VS et al. · 2026 · International dental journal · PMID 41812583Open on PubMed
  6. Randomized, open-label study of the short-term pharmacokinetics of oral magnesium oxide in healthy volunteers.Swetha RK, Gayathri B, Kumar V et al. · 2026 · Scientific reports · PMID 42091979Open on PubMed
  7. Magnesium supplementation did not reduce serum calciprotein crystallization and arterial stiffness in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Meer R, Xu JY, Newsom SP et al. · 2026 · The American journal of clinical nutrition · PMID 41903889Open on PubMed
  8. Magnesium supplementation as an adjunct to fluoxetine therapy for depression.Walyddaini AS, Lisal ST, Ilhamuddin et al. · 2026 · East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan · PMID 41916937Open on PubMed
  9. Magnesium Supplementation and Tachyarrhythmias: A Nonrandomized Clinical Trial.Goulden R, Abrahamowicz M, Strumpf E et al. · 2026 · JAMA internal medicine · PMID 41359319Open on PubMed
  10. Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation.Pickering ME, Morel V, Nicolas M et al. · 2026 · Aging clinical and experimental research · PMID 41566091Open on PubMed
  11. Comparison of oral ketorolac and oral magnesium for postoperative pain management in anorectal surgery: A randomized double-blind clinical trial.Eshagh Hoseini SJ, Ghazi FS, Eshraghi M et al. · 2026 · The Journal of international medical research · PMID 41529918Open on PubMed
  12. Impact of Preoperative Calcium and Magnesium Supplementation on Quality of Life and Hypocalcemia Post-Thyroidectomy.Tabriz N, Fried D, Uslar V et al. · 2026 · Endocrinology, diabetes & metabolism · PMID 41319240Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.